The 2nd ALS Drug Development Summit covers topics such as:
- Delineating Accurate Primary Outcome Measures to Correlate with Clinical Outcome
- Validating Biomarkers of Target Engagement & Disease Progression to Transform Early & Sensitive Indicators of Therapeutic Efficacy
- Interrogating Causative Genes & Cellular Pathways with Robust ALS Models to Recapitulate Disease Pathogenesis & Validate Targets
- Trial Design, Recruitment & Patient-Centric Approaches: Innovating Clinical Trials to Advance Effective Treatments
- Enlightening Pathophysiology of ALS & Clarifying Novel Pathways for Therapeutic Intervention
The 2nd ALS Drug Development Summit will be held in Boston on 16-18 May 2023.
